Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2026-04-08 @ 2:14 AM
Study NCT ID:
NCT05662904
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-03-14
First Post:
2022-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML
Sponsor:
German Cancer Research Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None